Creative Planning’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
JT
OCA
RCM
MB
PCH
Creative Planning's BIOA Position: Q2 2026 in Review
Creative Planning reduced its BioAge Labs (BIOA) stake by 27% in Q2 2026, selling an estimated $123K and leaving 18,535 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #3259.
Creative Planning first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.
- Creative Planning held 18,535 shares of BioAge Labs worth $454K as of Q2 2026.
- Creative Planning sold 6,786 BioAge Labs shares in Q2 2026, an estimated $123K.
- BioAge Labs made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3259 holding.
- Creative Planning first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
- 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.